ASPI logo

ASP ISOTOPES INC

ASPINASDAQ
🏆 #3124 by market capEarnings Nov 17US Equity
$2.64▲ $0.04 (+1.54%)
Market closed · at close
🔔
Track ASPI
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 1.5%
7d▼ 12.5%
14d▼ 16.1%
30d▼ 34.2%
ytd▼ 50.7%
1y▼ 72.6%
🏦Market Cap
$393M
Small Cap
📈Revenue Growth (YoY)
+573.4%
High Growth
📊Gross Margin
18.3%
Thin
💵FCF Margin
—
⚖️P/S Ratio
13.1x
Elevated
Otter Score
52
Weak

Trading Snapshot

Day Range
$2.62 – $2.66
52-Week Range
$2.51 – $14.49
Volume
$8.09B
Avg Volume
$7.21B
Shares Outstanding
149.1M
Next Earnings
Nov 2, 2026

Fundamentals Snapshot

Annual Revenue
$31M
Last Q Revenue
$7M
P/E Ratio
—
P/S Ratio
13.1x
EPS (TTM)
$-1.23
Dividend Yield
—
Dilution (1yr)
+32.5%

Why Investors Own ASPI

  • ✓High-growth profile — revenue up +9.1% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 61% gross margin and 22% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ASPI logo

ASP ISOTOPES INC

ASPI
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$24M▲ +475.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
14.3%▼ −63.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$57M▲ +117.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$47M▲ +69.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
93.6M▲ +32.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$70M▲ +$45M YoY
StockOtter · stockotter.space

About ASP ISOTOPES INC

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
52/100

Analyst Ratings

ⓘ
Consensus
Buy
9 analysts
Strong Buy2
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

🚀
Reuters·2h ago

ASP ISOTOPES INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
CNBC·5h ago

Analysts lift ASPI price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

ASP ISOTOPES INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.